Sign in

CIK 0001750149

  • Non-accelerated filer
  • Smaller reporting company

Inhibikase Therapeutics, Inc.

Sign in to watch
Ticker
IKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263407249
Phone
+1 302-295-3800
Business address
1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-02-14 Freeman Roy Lester Director Grant or award · Stock Option (Right to Buy) +22,640 22,640
2025-01-21 Freeman Roy Lester Director Returned to the company · Stock Option (Right to Buy) −21,854 0
2025-01-21 Freeman Roy Lester Director Grant or award · Stock Option (Right to Buy) +21,854 21,854
2025-01-21 Freeman Roy Lester Director Returned to the company · Stock Option (Right to Buy) −1,138 0
2025-01-21 Freeman Roy Lester Director Grant or award · Stock Option (Right to Buy) +1,138 1,138
2025-01-21 Freeman Roy Lester Director Returned to the company · Stock Option (Right to Buy) −3,780 0
2025-01-21 Freeman Roy Lester Director Grant or award · Stock Option (Right to Buy) +3,780 3,780
2025-01-21 Freeman Roy Lester Director Returned to the company · Stock Option (Right to Buy) −6,667 0
2025-01-21 Freeman Roy Lester Director Grant or award · Stock Option (Right to Buy) +6,667 6,667
2025-01-21 Freeman Roy Lester Director Returned to the company · Stock Option (Right to Buy) −6,667 0
2025-01-21 Freeman Roy Lester Director Grant or award · Stock Option (Right to Buy) +6,667 6,667
2025-01-21 Freeman Roy Lester Director Returned to the company · Stock Option (Right to Buy) −30,000 0
2025-01-21 Freeman Roy Lester Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2025-01-03 Freeman Roy Lester Director Grant or award · Stock Option (Right to Buy) +344,452 344,452
2025-01-03 Freeman Roy Lester Director Grant or award · Stock Option (Right to Buy) +172,191 172,191
2025-01-03 Freeman Roy Lester Director Grant or award · Stock Option (Right to Buy) +316,647 316,647
2024-07-16 Freeman Roy Lester Director Grant or award · Stock Option (right to buy) +30,000 30,000
2023-06-30 Freeman Roy Lester Director Grant or award · Stock Option (right to buy) +6,667 6,667
2022-06-24 Freeman Roy Lester Director Grant or award · Stock Option (right to buy) +40,000 40,000
2021-06-25 Freeman Roy Lester Director Grant or award · Stock Option (right to buy) +22,677 22,677

Page 1 of 2 · 21 trades